Mode
Text Size
Log in / Sign up

Respiratory Viral Infections

Part of Respiratory Tract Infections

5 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Respiratory Viral Infections

5 trials tracked for Respiratory Viral Infections: 1 in phase 3 or 4 and 1 with published results. The most-cited published study has 1 citation.

5Trials tracked
1Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 2 1 Phase 1 1 Other / NA 2
  1. Phase 4 Pilot of Cohort of Households for Influenza Monitoring and Evaluation in Seattle Completed · 1 cited
  2. Phase 2 An Open Label Study in Adults to Test the Efficacy of Mitoquinone/Mitoquinol Mesylate to Prevent Severe Viral Illness Completed
  3. Phase 1 Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age Completed
  4. N/A New Reusable Mask Design With Superior Filtration and Fit Completed
  5. N/A The Development of a Human Model of Respiratory Syncytial Virus Infection Completed

Showing the 5 most-cited and recently-updated of 5 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found For clinicians

Respiratory Viral Infections: what the trials found

Baloxavir Marboxil is utilized as an antiviral intervention for respiratory viral infections. Clinical data indicates that the treatment was successfully delivered within 48 hours of symptom onset in a cohort of patients.

The administration of Baloxavir Marboxil followed specific protocols regarding timing, with evidence supporting its use as a targeted therapy for these conditions.

Recent results — preliminary, needs further review

  • MED-534 was evaluated for the reduction of vaccine-like virus shedding; results showed 0 participants shedding at 28 days post-dose.
  • Mitoquinone/mitoquinol mesylate and N95 masks were investigated in preliminary phases but do not have established clinical outcomes.

For the clinician treating this condition

  • Baloxavir Marboxil is an established intervention for respiratory viral infections, with evidence supporting its administration within a 48-hour window of symptom onset.
  • Clinical focus remains on the timing of antiviral delivery to optimize patient outcomes.

AI synthesis of 0 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Respiratory Tract Infections

Related studies from across the Respiratory Tract Infections family.

Impact of Rapid Multiplex Point of Care Testing on Antibiotic Prescribing
Infectious Disease RCT
Impact of Rapid Multiplex Point of Care Testing on Antibiotic Prescribing Rapid testing shows mixed results for reducing common antibiotic use
A randomized trial evaluates if rapid multiplex testing reduces same-day antibiotic prescriptions for respiratory infections in children and…
A new rapid test to identify respiratory viruses did not reduce overall antibiotic prescriptions, but showed potential for specific patient …
Host factors influence viral entry and replication in HPIV infected infants, elderly, and immunocompromised individuals
Genetics & Precision Medicine Sys. Review
Host factors influence viral entry and replication in HPIV infected infants, elderly, and immunocompromised individuals Host factors influence how the parainfluenza virus infects vulnerable people
This narrative review discusses host factors influencing viral entry, replication, assembly, release, and innate immunity evasion in human p…
A review explains how host factors affect viral entry and immunity in infants, the elderly, and immunocompromised individuals with respirato…
Prospective paired-sample study reviews AveloMask XBA sampling versus lower respiratory tract specimens in hospitalized pneumonia patients
Infectious Disease
Prospective paired-sample study reviews AveloMask XBA sampling versus lower respiratory tract specimens in hospitalized pneumonia patients Your Breath Could Diagnose Pneumonia Without a Needle
This prospective paired-sample study evaluated exhaled breath aerosol (XBA) sampling using the AveloMask against lower respiratory tract (LR…
A new face mask device might soon replace painful tests for pneumonia diagnosis.
Parechovirus A detection linked to pharyngitis and tonsillitis in children across hospital and day-care settings
Pediatrics Cohort
Parechovirus A detection linked to pharyngitis and tonsillitis in children across hospital and day-care settings This common virus may be behind your child’s sore throat
This observational cohort study evaluated 323 hospitalized children and 30 day-care attendees for parechovirus A (PeV-A) alongside other res…
A common virus called PeV-A is linked to sore throats in kids and helps explain why some children get sick when others stay healthy.
Review of prospective cohort study on post-diarrhea respiratory infections in children
Infectious Disease
Review of prospective cohort study on post-diarrhea respiratory infections in children After severe diarrhea, nearly 4 out of 100 young children in low-income countries get a new lung infection within three months
This review summarizes a prospective cohort study of 9,116 children aged 6-35 months with medically-attended diarrhea across seven sites.
After severe diarrhea, nearly 4 out of 100 young children in low-income countries get a new lung infection within three months.
tNGS in pediatric LRTIs shows higher Mycoplasma pneumoniae detection in severe vs non-severe CAP
Infectious Disease Cohort
tNGS in pediatric LRTIs shows higher Mycoplasma pneumoniae detection in severe vs non-severe CAP A new test found more germs in severe pediatric pneumonia cases than mild ones
A retrospective, single-center cohort study of 2,299 children with suspected lower respiratory tract infections found that targeted next-gen…
A new test found that severe pediatric pneumonia cases carry more germs than mild ones, revealing a link between specific microbial signatur…
Relaxation of COVID-19 NPIs in Nanjing children showed high pathogen detection rates with preschoolers having the highest burden
Infectious Disease Cohort
Relaxation of COVID-19 NPIs in Nanjing children showed high pathogen detection rates with preschoolers having the highest burden When COVID rules lifted, did kids get sicker or just catch more common bugs?
This retrospective cohort study examined 7,473 children (≤18 years) presenting with acute respiratory tract infections in a tertiary hospita…
After COVID rules lifted, common cold viruses and bacteria caused most children's breathing issues, with young kids facing the highest risk …
Meta-analysis links asthma, passive smoking, and frequent snacks to recurrent respiratory infections in preschoolers
Pediatrics Meta-analysis
Meta-analysis links asthma, passive smoking, and frequent snacks to recurrent respiratory infections in preschoolers Three habits that spark repeated colds in toddlers
A meta-analysis of observational studies involving 170,915 preschool children globally identified asthma (OR=3.26), passive smoking (OR=1.50…
Parents can lower their child's risk of repeated infections by managing asthma, keeping homes smoke-free, and limiting frequent snacking.
Surveillance data show summer 2022 increases in pediatric acute respiratory illness and asthma
Allergy & Immunology
Surveillance data show summer 2022 increases in pediatric acute respiratory illness and asthma U.S. surveillance data shows summer increase in childhood respiratory illnesses
A U.S. surveillance report noted increases in acute respiratory illness and asthma/reactive airway disease among children and adolescents du…
U.S. surveillance data shows an increase in childhood respiratory illnesses and asthma reports during the summer of 2022.
Surveillance report describes respiratory virus patterns in children with acute respiratory illnesses
Pediatrics
Surveillance report describes respiratory virus patterns in children with acute respiratory illnesses U.S. surveillance tracks respiratory viruses in children with acute illnesses
A surveillance report from the United States describes respiratory virus patterns among children with acute respiratory illnesses.
U.S. health officials are tracking respiratory viruses in sick children to watch for patterns, but this report offers no new medical guidanc…
High Infection Rates in Type 2 Diabetes: Periodontitis Prevalence at 33.6%
Diabetes & Endocrinology Meta-analysis
High Infection Rates in Type 2 Diabetes: Periodontitis Prevalence at 33.6% Are Infections Hitting People with Type 2 Diabetes Harder Than We Thought?
This meta-analysis found severe periodontitis prevalence at 33.6% (95% CI: 23.7-44.2) and lower respiratory tract infection incidence at 140…
People with type 2 diabetes face higher rates of severe gum disease and frequent lung infections, making infection prevention a critical par…

Questions about Respiratory Viral Infections

Are there different risks after SARS-CoV-2 compared to other types of Respiratory Viral Infections?

While some symptoms like brain fog or heart palpitations are more common after SARS-CoV-2 than other respiratory viruses, both types of infections can lead to serious complications such as pneumonia and cardiovascular issues.

Full answer →
What are the current trends for Respiratory Viral Infections across the United States?

Respiratory viral infections like SARS-CoV-2, influenza, and RSV are frequently monitored in the U.S., with varying impacts on patient outcomes such as hypoxemia and mortality.

Full answer →
How did influenza and other Respiratory Viral Infections circulate during the COVID pandemic?

During the COVID-19 pandemic, the detection of common respiratory viruses like influenza and RSV significantly decreased in pediatric settings.

Full answer →